Annual Accounts Receivable:
N/ASummary
- TNGX annual accounts receivable is not available.
Performance
TNGX Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Range
Earnings dates
Quarterly Accounts Receivable:
N/ASummary
- TNGX quarterly accounts receivable is not available.
Performance
TNGX Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Range
Earnings dates
Accounts Receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
TNGX Accounts Receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1Y1 Year | - | - |
| 3Y3 Years | - | - |
| 5Y5 Years | - | - |
TNGX Accounts Receivable Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | |
|---|---|---|---|---|---|
| 3Y | 3-Year | ||||
| 5Y | 5-Year | ||||
| All-Time | All-Time |
TNGX Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2023 | $0.00(-100.0%) | $0.00(0.0%) |
| Sep 2023 | - | $0.00(0.0%) |
| Jun 2023 | - | $0.00(0.0%) |
| Mar 2023 | - | $0.00(-100.0%) |
| Dec 2022 | $2.00M | $2.00M(0.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $2.00M(0.0%) |
| Jun 2022 | - | $2.00M(0.0%) |
| Mar 2022 | - | $2.00M(0.0%) |
| Dec 2021 | $2.00M(0.0%) | $2.00M(-75.0%) |
| Sep 2021 | - | $8.00M(+300.0%) |
| Dec 2020 | $2.00M | $2.00M |
FAQ
- What is the all-time high annual accounts receivable for Tango Therapeutics, Inc.?
- What is the all-time high quarterly accounts receivable for Tango Therapeutics, Inc.?
What is the all-time high annual accounts receivable for Tango Therapeutics, Inc.?
Tango Therapeutics, Inc. all-time high annual accounts receivable is $2.00M
What is the all-time high quarterly accounts receivable for Tango Therapeutics, Inc.?
Tango Therapeutics, Inc. all-time high quarterly accounts receivable is $8.00M